Supernus Pharmaceuticals, Inc.
supernus.com
Actively hiring
Neurology & CNS Therapeutics
Biologics & Biosimilars
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
Read more
Report
Report
Supernus Pharmaceuticals Partners with Busy Philipps for "Ms. Represented" Campaign to Empower Women with ADHD
Busy Philipps partners with Supernus Pharmaceuticals to launch a campaign addressing ADHD in women, sharing her personal journey with Qelbree.
Read more
Report
Supernus Pharmaceuticals Reports 44% Increase in Qelbree Sales and Launches ONAPGO in Q1 2025
Supernus Pharmaceuticals reported significant first-quarter revenue growth and launched ONAPGO for Parkinson's disease treatment.
Read more
Report
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
Read more
Report
SPN Corporate Transparency in Coverage
SPN Corporate Transparency in Coverage div class="field field--name-fie...
Read more
Report
Copy of SPN Corporate Corporate Compliance - Code of Ethics
Copy of SPN Corporate Corporate Compliance - Code of Ethics div class="...
Read more
Report
Show more news